Pulsenmore Receives FDA De Novo Marketing Authorization for Home-Use Prenatal Ultrasound, Pioneering a New Era of Prenatal Care in the U.S.
RAMAT GAN, Israel , Nov. 3, 2025 /PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted...
Home Ultrasound Developer Pulsenmore Establishes European Operations and Appoints General Manager
/PRNewswire/ -- Pulsenmore Ltd. (TASE: PULS), a global leader in self-scan ultrasound devices for remote clinical diagnosis, has appointed Mr. Johannes Scheibl...